Life Sciences
USA Guide 2024 : Massachusetts
Band 2
Email address
[email protected]Contact number
+1 617 542 6000About
Provided by Mintz
Mintz’s Life Sciences Practice boasts 200+ attorneys across the firm's seven offices serving life sciences companies in the United States and internationally.
• Embedded in the life sciences ecosystem since its birth in the 1970s, working with innovators, investors, and multinational companies to navigate the complex regulatory and business environment
• From pre-clinical research through commercialization and beyond, this interdisciplinary group delivers a full spectrum of support and creative solutions for life sciences companies
• Significant transactional experience for life sciences companies including IPOs, mergers and acquisitions, joint ventures, licensing and complex collaborations, distribution deals, and private financings
• Intellectual Property practice of more than 115 professionals who represent clients in prosecution, strategy, business transactions, and litigation – more than 30 of whom have biology or chemistry PhDs
• National reputation as go-to firm for high-stakes life sciences litigation, with an exemplary record in resolving disputes with collaboration/licensing partners and representing corporate officers and directors of life sciences companies in disputes
• Regulatory and compliance advice spanning FDA strategy and interactions, clinical trials, fraud and abuse, compliance program development, HIPAA, marketing and advertising, drug pricing and reimbursement, supply and distribution agreements
Chambers Review
Mintz's Boston team has broad and deep experience advising life sciences sector clients. The team is particularly adept representing and counseling clients on transactional matters, including licensing and collaboration agreements, M&A, IPOs and venture capital financing.
Work Highlights
- Mintz represented Hopewell Therapeutics, a biotechnology company with a differentiated lipid nanoparticle platform harnessing unique ionizable lipid chemistry, in its Seed Financing of up to $25 million.
Notable Practitioners
John Cheney is typically called upon by life sciences companies of all sizes to advise on joint venture agreements and licensing matters.